Suppr超能文献

在存在相互竞争风险的情况下权衡风险与收益。

Weighing risks and benefits in the presence of competing risks.

作者信息

Lesko Catherine R, Zalla Lauren C, Heyward James, Joseph Corey, Edwards Jessie K

机构信息

Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, MD 21205.

Department of Epidemiology, University of North Carolina, Chapel Hill, NC 27559.

出版信息

Curr Epidemiol Rep. 2023 Dec;10(4):221-239. doi: 10.1007/s40471-023-00331-1. Epub 2023 Sep 22.

Abstract

PURPOSE OF REVIEW

When competing events occur, there are two main options for handling them analytically that invoke different assumptions: 1) censor person-time after a competing event (which is akin to assuming they could be prevented) to calculate a conditional risk; or 2) do not censor them (allow them to occur) to calculate an unconditional risk. The choice of estimand has implications when weighing the relative frequency of a beneficial outcome and an adverse outcome in a risk-benefit analysis.

RECENT FINDINGS

We review the assumptions and interpretations underlying the two main approaches to analyzing competing risks. Using a popular metric in risk-benefit analyses, the Benefit-Risk Ratio, and a toy dataset, we demonstrated that conclusions about whether a treatment was more beneficial or more harmful can depend on whether one uses conditional or unconditional risks.

SUMMARY

We argue that unconditional risks are more relevant to decision-making about exposures with competing outcomes than conditional risks.

摘要

综述目的

当出现竞争事件时,在进行分析处理时有两种主要方法,它们基于不同的假设:1)在竞争事件发生后审查个体时间(这类似于假设它们可以被预防)以计算条件风险;或2)不审查它们(允许它们发生)以计算无条件风险。在权衡风险效益分析中有益结果和不良结果的相对频率时,估计量的选择具有重要意义。

最新发现

我们回顾了分析竞争风险的两种主要方法背后的假设和解释。使用风险效益分析中一种常用的指标——效益风险比,以及一个简单数据集,我们证明了关于一种治疗是更有益还是更有害的结论可能取决于使用的是条件风险还是无条件风险。

总结

我们认为,与条件风险相比,无条件风险在关于具有竞争结果的暴露的决策中更具相关性。

相似文献

1
Weighing risks and benefits in the presence of competing risks.在存在相互竞争风险的情况下权衡风险与收益。
Curr Epidemiol Rep. 2023 Dec;10(4):221-239. doi: 10.1007/s40471-023-00331-1. Epub 2023 Sep 22.
4
5
Causal inference in the face of competing events.面对竞争事件时的因果推断。
Curr Epidemiol Rep. 2020 Sep;7(3):125-131. doi: 10.1007/s40471-020-00240-7. Epub 2020 Jul 12.
10
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.

本文引用的文献

2
A Framework for Descriptive Epidemiology.描述性流行病学框架。
Am J Epidemiol. 2022 Nov 19;191(12):2063-2070. doi: 10.1093/aje/kwac115.
4
On the Need to Revitalize Descriptive Epidemiology.有必要复兴描述性流行病学。
Am J Epidemiol. 2022 Jun 27;191(7):1174-1179. doi: 10.1093/aje/kwac056.
7
Benefit-Risk Tradeoffs in Assessment of New Drugs and Devices.新药和新器械评估中的获益-风险权衡。
Circulation. 2020 Nov 17;142(20):1974-1988. doi: 10.1161/CIRCULATIONAHA.120.048933. Epub 2020 Nov 16.
10
Hidden Imputations and the Kaplan-Meier Estimator.潜在影响因素与 Kaplan-Meier 估计量。
Am J Epidemiol. 2020 Nov 2;189(11):1408-1411. doi: 10.1093/aje/kwaa086.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验